Raichur R&D Unit

The Research & Development activities at Shilpa Medicare's Raichur facility are designed to be carried out in full compliance to sound Intellectual Property principles in vogue. The product pipeline and patent portfolio management is efficiently harmonized and overseen by the Intellectual Property Management & Legal Affairs Cell, making Raichur our flagship innovation center.

While we protect our IP credentials with stringent benchmarks, due diligence precedes before ours' conceding authentic and valid IP rights of competitors. It is paramount at Shilpa's that products with valid patents are available only on R & D scale and on no account offered for commercial activities as mandated under the provisions of the Indian Patent (Amendments) Act, 2016.

While being highly competitive, we are also open for assigning, licensing, cross-licensing and entering into collaborations with respect to our Intellectual Property assets, at mutually agreeable terms and conditions.

Driving innovation and maximizing value through its operations, Shilpa Medicare's Raichur R&D Unit is a proud recipient of prestigious IPM awards that recognize our commitment to pharmaceutical excellence and intellectual property development.